3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow CD20 Positive: new trials by email Literature Review of CD20 Positive trials Research Report on CD20 Positive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma Ibrutinib, Laboratory Biomarker Analysis, Lenalidomide - Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 48 | 2016-04-11 | 2024-09-24 |
| Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Cyclophosphamide, Cytarabine, Dexamethasone - Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission | Phase 2 | Completed | M.D. Anderson Cancer Center | 72 | 2011-07-12 | 2021-05-03 |
| Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant Allogeneic Hematopoietic Stem Cell Transplantation, Anti-Thymocyte Globulin, Bortezomib - CD20 Positive, Hematopoietic and Lymphoid Cell Neoplasm | Phase 2 | Completed | M.D. Anderson Cancer Center | 40 | 2007-02-13 | 2019-09-10 |
Burkitt Lymphoma (1) · Hematologic Neoplasms (1) · Lymphoma (1) · Lymphoma, Follicular (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Hematologic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Herpesviridae Infections (1) · Infections (1) · Leukemia (1)
CT-P10 (2) · Cytarabine (2) · Methotrexate (2) · Rituximab (2) · merphos (2) · Antilymphocyte Serum (1) · Bortezomib (1) · Calcium Dobesilate (1) · Carmustine (1) · Cyclophosphamide (1) · Dexamethasone (1) · Doxorubicin (1) · Etoposide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1)
M.D. Anderson Cancer Center (3)
United States (3)
Elias Jabbour (1) · Issa Khouri (1) · Loretta J Nastoupil (1)
PMID 32589978, PMID 34138471, PMID 35622074, PMID 37985359
P30CA016672 (1)